Table 1 Baseline characteristics of 268 HIV patients at time of initiation of antiretroviral therapy randomized to lipid-based nutrient supplements or no supplements
Characteristics | Non-supplemented (n = 89)a | Supplemented (n = 179)a |
|---|---|---|
Age (years) | 32 ± 9 | 33 ± 9 |
Women, n (%) | 63 (70.8) | 117 (65.4) |
Educational status | ||
No schooling, n (%) | 27 (30.3) | 40 (22.4) |
Primary education, n (%) | 44 (49.4) | 103 (57.5) |
Secondary and higher education, n (%) | 18 (20.2) | 36 (20.1) |
Body mass index (kg/m2) | 19.8 ± 2.1 | 19.9 ± 2.3 |
Weight (kg) | 51.4 ± 7.3 | 54.2 ± 7.4 |
Waist circumference (cm) | 71.9 ± 6.7 | 73.0 ± 6.5 |
C-reactive protein (mg/L)b | 2.1 (0.6–7.5) | 1.6 (0.5–5.5) |
HIV-related characteristics | ||
WHO stage | ||
Stage I, n (%) | 25 (28.4) | 61 (34.1) |
Stage II, n (%) | 26 (29.6) | 58 (32.4) |
Stage III, n (%) | 29 (33.0) | 44 (24.6) |
Stage IV, n (%) | 8 (9.1) | 16 (8.9) |
HIV viral load (log (1+ copies/mL)) | 4.7 ± 0.8 | 4.8 ± 0.8 |
CD4 count (cells/μl) | 191 ± 107 | 185 ± 101 |
CD8 count (cells/μl) | 878 ± 416 | 871 ± 426 |